Edoxaban monotherapy superior to dual therapy in patients with high-risk AF and stable CAD

Edoxaban monotherapy reduced net adverse clinical events compared with edoxaban plus a single antiplatelet agent, when used as long-term antithrombotic therapy, in patients with high-risk atrial fibrillation (AF) and stable coronary artery disease (CAD), according to late-breaking research presented in a Hot Line session today at ESC Congress 2024.

Massachusetts becomes first state to blanket pardon low-level marijuana charges – The Cannabist

Massachusetts is now the first state to pardon the crimes of offenders charged with simple pot possession — after President Joe Biden did the same

October 11, 2024

Alcohol plus cabin pressure at higher altitude may threaten sleeping plane passengers’ heart health

The combination of alcohol plus cabin pressure at cruising altitude may threaten sleeping plane passengers’ heart health, particularly on long haul flights, suggests the first

June 4, 2024

Interventional Systems gets second 510(k) clearance for miniature robot

Dive Brief: Austria-based Interventional Systems said it has picked up a second 510(k) authorization for its table-mounted robotic platform designed for percutaneous procedures. The Food

October 19, 2023

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.